Page 15 - Panel On News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Momentum is starting to grow to get more Americans vaccinated and stop the spread of the more infectious Delta variant.  A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: CDC encourages use of new tests that detect both COVID-19 and the flu CLAIM: The Centers for Disease Control and Prevention revoked Emergency Use Authorization for coronavirus PCR tests because they were inaccurate, led to false positives and co...

Sunday, July 25, 2021 by: Mike Adams Bypass censorship by sharing this link: https://www.afinalwarning.com/538670.html (Natural News) After more than a year of committing scientific fraud to push false “positives” via PCR testing, the CDC has announced it is withdrawing the RT-PCR Diagnostic Panel on December 31st of this year: After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February ...

Corona-News | Virologin Brinkmann fordert Lolli-Tests an Schulen Newsblog zu Covid-19   Virologin Brinkmann fordert Lollitests an Schulen 04.07.2021, 01:33 Uhr | t-online, dpa, rtr, AFP Prof. Melanie Brinkmann bei einer Pressekonferenz (Archivbild). Die Virologin sorgt sich um die Ausbreitung der Delta-Variante in Schulen. (Quelle: Jens Schicke/imago images) Redaktion Die Virologin Melanie Brinkmann will die Testkonzepte an Schilen überdenken. Mit Gruppentests lasse sich schneller und präziser erkennen, ob die Delta-Variante in den Klassenzimmern angekommen ist.  Alle Infos im News...

Corona-News | Hausärzte fürchten Chaos bei Impfterminen Newsblog zu Covid-19   Ärzte: Patienten wegen Kreuzimpfung verunsichert 03.07.2021, 08:53 Uhr | t-online, dpa, rtr, AFP Eine Ärztin im Kreis Ludwigsburg impft Patientin gegen Corona (Archivbild). Die Vereinigung der Hausärzte sieht Probleme wegen der Kreuzimpfung. (Quelle: Wilhelm Mierendorf/imago images) Redaktion Die Hausärzte fürchten logistische Probleme und Termin-Chaos nach der neuen Stiko-Entscheidung, Astrazeneca-Geimpften jetzt mRNA-Impfstoffe zu geben. Alle Infos im Newsblog. In Deutschland haben sich seit Beginn...

(1) SOUTH SAN FRANCISCO (dpa-AFX) - Today's Daily Dose brings you news about the clinical hold imposed by the FDA on Larimar's CTI-1601 clinical program; Pieris Pharma teaming up with Roche's Genentech; the upcoming regulatory catalyst of Provention Bio; the possible delay in Travere seeking approval for Sparsentan; and the approval of Taiwan Liposome's Liposomal Amphotericin B injection in India to fight the growing cases of black fungus. Read on. 1. Larimar Plunges On Double Dose Of Bad News Shares of Larimar Therapeutics, Inc. (LRMR) took a hit Tuesday, following a double dose of bad news....